<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Onco Targets Ther</journal-id>
<journal-id journal-id-type="iso-abbrev">Onco Targets Ther</journal-id>
<journal-id journal-id-type="publisher-id">OTT</journal-id>
<journal-id journal-id-type="pmc">ott</journal-id>
<journal-title-group>
<journal-title>OncoTargets and therapy</journal-title>
</journal-title-group>
<issn pub-type="epub">1178-6930</issn>
<publisher>
<publisher-name>Dove</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31190864</article-id>
<article-id pub-id-type="pmc">6526180</article-id>
<article-id pub-id-type="publisher-id">207546</article-id>
<article-id pub-id-type="doi">10.2147/OTT.S207546</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Novel cancer therapy targeting microbiome</article-title>
<alt-title alt-title-type="running-authors">Nagano et al</alt-title>
<alt-title alt-title-type="running-title">Nagano et al</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Nagano</surname>
<given-names>Tatsuya</given-names>
</name>
<xref ref-type="corresp" rid="AN0001"></xref>
<xref ref-type="aff" rid="AFF0001">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Otoshi</surname>
<given-names>Takehiro</given-names>
</name>
<xref ref-type="aff" rid="AFF0001">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hazama</surname>
<given-names>Daisuke</given-names>
</name>
<xref ref-type="aff" rid="AFF0001">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kiriu</surname>
<given-names>Tatsunori</given-names>
</name>
<xref ref-type="aff" rid="AFF0001">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Umezawa</surname>
<given-names>Kanoko</given-names>
</name>
<xref ref-type="aff" rid="AFF0001">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Katsurada</surname>
<given-names>Naoko</given-names>
</name>
<xref ref-type="aff" rid="AFF0001">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nishimura</surname>
<given-names>Yoshihiro</given-names>
</name>
<xref ref-type="aff" rid="AFF0001">1</xref>
</contrib>
<aff id="AFF0001"><label>1</label><institution>Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine</institution>, <addr-line>Kobe</addr-line>
<addr-line>650-0017</addr-line>, <country>Japan</country></aff>
</contrib-group>
<author-notes>
<corresp id="AN0001">Correspondence: Tatsuya Nagano<institution>Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine</institution>, <addr-line>7-5-1 Kusunoki-cho, Chuo-ku</addr-line>, <addr-line>Kobe</addr-line><addr-line>650-0017</addr-line>, <country>Japan</country><phone>Tel +81 78 382 5660</phone><fax>Fax +81 78 382 5661</fax> Email <email xlink:href="tnagano@med.kobe-u.ac.jp">tnagano@med.kobe-u.ac.jp</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>13</day>
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>12</volume>
<fpage>3619</fpage>
<lpage>3624</lpage>
<history>
<date date-type="received">
<day>04</day>
<month>3</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>4</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 Nagano et al.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Nagano et al.</copyright-holder>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
<license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<title>Abstract</title>
<p>In the human intestinal tract, there are more than 100 trillion symbiotic bacteria, which form the gut microbiota. Approximately 70% of the human immune system is in the intestinal tract, which prevents infection by pathogenic bacteria. When the intestinal microbiota is disturbed, causing dysbiosis, it can lead to obesity, diabetes mellitus, inflammatory bowel disease, rheumatoid arthritis, multiple sclerosis, autism spectrum disorder and cancer. Recent metabolomics analyses have also made the association between the microbiota and carcinogenesis clear. Here, we review the current evidence on the association between the microbiota and gastric, bladder, hepatobiliary, pancreatic, lung and colorectal cancer. Moreover, several animal studies have revealed that probiotics seem to be effective for the prevention of carcinogenesis to some extent. In this review, we focused on this relationship between the microbiota and cancer, and considered how to prevent cancer using strategies involving the gut microbiota.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords</title>
<kwd>dysbiosis</kwd>
<kwd>prebiotics</kwd>
<kwd>probiotics</kwd>
<kwd>antibiotics</kwd>
</kwd-group>
<counts>
<ref-count count="74"></ref-count>
<page-count count="6"></page-count>
</counts>
</article-meta>
</front>
<body>
<sec id="S0001">
<title>Introduction</title>
<sec id="S0001-S2001">
<title>Gut microbiota</title>
<p>The human microbiota is a complex ecosystem of bacteria, viruses and fungi resident on or in the skin, oral cavity, lungs, intestines and vagina.<xref ref-type="bibr" rid="CIT0001">1</xref> The human gastrointestinal tract is colonized by a complex and abundant microbial community of 10<sup>13</sup> to 10<sup>14</sup> microorganisms in the colon.<xref ref-type="bibr" rid="CIT0002">2</xref>,<xref ref-type="bibr" rid="CIT0003">3</xref>
<italic>Firmicutes, Proteobacteria, Bacteroidetes</italic> and <italic>Acinetobacteria</italic> are major residents in normal bowels.</p>
<p>The commensal microbiota is a major regulator of the host immune system. Indeed, early innate immunity to <italic>Klebsiella pneumoniae</italic> in the lungs is regulated systemically by the commensal gut microbiota via Nod-like receptor (NLR) ligands.<xref ref-type="bibr" rid="CIT0003">3</xref> Segmented filamentous bacteria (SFB) not only induce cells that produce immunoglobulin A (IgA) and intraepithelial lymphocytes (IELs), but also promote host defense reactions and the accumulation of T helper type 17 (Th17) cells, which produce interleukin (IL)-17.<xref ref-type="bibr" rid="CIT0004">4</xref>,<xref ref-type="bibr" rid="CIT0005">5</xref> Moreover, <italic>Clostridium</italic> enhances the differentiation and proliferation of regulatory T (Treg) cells.<xref ref-type="bibr" rid="CIT0006">6</xref>,<xref ref-type="bibr" rid="CIT0007">7</xref></p>
<p>In addition to these functions, the microbiota has a role in the synthesis of vitamins and short-chain fatty acids from dietary fiber such as acetic acid, propionic acid and butyric acid. Although acetic acid and amino acids do not have a role in the differentiation and induction of Treg cells, butyric acid has a crucial role.<xref ref-type="bibr" rid="CIT0008">8</xref> Additionally, short-chain fatty acids bind to G protein-coupled receptors and regulate obesity.<xref ref-type="bibr" rid="CIT0009">9</xref> Numerous clinical studies have revealed that disruption of host–commensal interactions (dysbiosis) can lead to a variety of diseases and conditions,<xref ref-type="bibr" rid="CIT0010">10</xref>–<xref ref-type="bibr" rid="CIT0022">22</xref> including cancer,<xref ref-type="bibr" rid="CIT0016">16</xref> chronic intestinal inflammation,<xref ref-type="bibr" rid="CIT0020">20</xref>,<xref ref-type="bibr" rid="CIT0023">23</xref> autoimmunity<xref ref-type="bibr" rid="CIT0022">22</xref> and impairment of the self-protection mechanisms against bacteria, viruses and parasites.<xref ref-type="bibr" rid="CIT0010">10</xref>,<xref ref-type="bibr" rid="CIT0012">12</xref>,<xref ref-type="bibr" rid="CIT0024">24</xref>–<xref ref-type="bibr" rid="CIT0032">32</xref></p>
<p>Lofgren et al demonstrated that germ-free INS-GAS mice were slower to develop atrophic gastritis and gastric cancer than specific pathogen free (SPF) INS-GAS mice.<xref ref-type="bibr" rid="CIT0033">33</xref> This result suggest that the gastric microbiota contributes to gastric cancer.</p>
</sec>
</sec>
<sec id="S0002">
<title>Microbiota and cancer</title>
<p>Several studies have shown that the colonic microbiota is associated with the development of colorectal cancer. In a chemically induced mouse model of colorectal cancer, transplantation of the fecal microbiota from colorectal cancer patients to germ-free mice increased susceptibility to colonic tumorigenesis.<xref ref-type="bibr" rid="CIT0034">34</xref></p>
<p>The hypotheses regarding the microbiota-related mechanisms of carcinogenesis in colorectal cancer include the following: the alpha-bug hypothesis, driver-passenger hypothesis, biofilm hypothesis and bystander effect hypothesis.<xref ref-type="bibr" rid="CIT0035">35</xref> The alpha-bug hypothesis posits that specific pathogenic bacteria induce colorectal cancer. For example, enterotoxigenic <italic>Bacteroides fragilis</italic> (ETBF) secretes <italic>Bacteroides fragilis</italic> toxin (BFT), which decreases E-cadherin levels. This loosens the attachments between intestinal epithelial cells and results in exposure to many antigens.<xref ref-type="bibr" rid="CIT0036">36</xref> Moreover, decreased E-cadherin promotes intracellular migration of β-catenin and accelerates carcinogenic-related signaling such as Wnt signaling. The driver-passenger hypothesis postulates that other bacteria, that is, passenger bacteria that adapt to the tumor environment produced by the driver bacteria, proliferate, leading to carcinogenesis. <italic>Fusobacterium nucleatum</italic> has an antagonistic effect against probiotics and has a role as a tumor-associated bacterium or oncobacterium.<xref ref-type="bibr" rid="CIT0037">37</xref>,<xref ref-type="bibr" rid="CIT0038">38</xref> The biofilm hypothesis suggests that biofilm, produced by the gut microbiota, is associated with colorectal cancer carcinogenesis, which involves lack of E-cadherin or activation of signal transducers and activator of transcription (STAT)-3. Lastly, the bystander effect hypothesis involves gut microbiota-produced metabolites that induce colorectal cancer carcinogenesis.</p>
<p>Deoxycholic acid and lithocholic acid, secondary bile acids produced from bile acids by intestinal bacteria, induce DNA damage and contribute to carcinogenesis.<xref ref-type="bibr" rid="CIT0039">39</xref> In mice that are prone to developing cancer, mice with diet-induced and hereditary obesity develop significantly more liver cancer than mice on a normal diet.<xref ref-type="bibr" rid="CIT0040">40</xref> Moreover, deoxycholic acid-induced DNA damage in hepatic stellate cells in the liver interstitium become senescent and secrete many inflammatory cytokines and proteases (senescence-associated secretory phenotype, SASP). These promote carcinogenesis and form a microenvironment that further promotes carcinogenesis. IL-1β promotes liver cancer carcinogenesis. Intriguingly, in obese mice administered oligosaccharides that inhibit deoxycholic acid and ursodeoxycholic acid production (which promotes external release of bile acids), the incidence of liver cancer and hepatic stellate cell senescence are remarkably decreased. Moreover, lipoteichoic acid, which is a component of Gram-positive bacterial walls and a ligand of Toll-like receptor 2 (Tlr2), increases in liver cancer and upregulates cyclooxygenase-2 (Cox-2) expression.<xref ref-type="bibr" rid="CIT0041">41</xref> Increased Cox-2 expression induces the overproduction of prostaglandins. An antagonist of prostaglandin E2 receptor 4 (EP4) has been shown to decrease liver tumors in obese mice.<xref ref-type="bibr" rid="CIT0042">42</xref> In addition, the EP4 antagonist also decreases programmed death-1 (PD-1)-positive CD8-positive T and Treg cells.</p>
<p>Several studies showed that bladder microbiome was related to urothelial cell carcinoma pathogenesis or progression.<xref ref-type="bibr" rid="CIT0043">43</xref> Bladder microbiome act as a noninvasive biomarker and can be a target of immunotherapy agents such as intravesical bacillus Calmette-Guerin.</p>
</sec>
<sec id="S0003">
<title>Oral microbiota and pancreatic cancer</title>
<p>The human oral cavity is colonized by many bacteria, including about 600 prevalent taxa at the species level.<xref ref-type="bibr" rid="CIT0044">44</xref> Indeed, the Human Oral Microbiome Database (HOMD) includes 619 taxa in the following 13 phyla: <italic>Actinobacteria, Bacteroidetes, Chlamydiae, Chloroflexi, Euryarchaeota, Firmicutes, Fusobacteria, Proteobacteria, Spirochaetes, SR1, Synergistetes, Tenericutes</italic> and <italic>TM7</italic>. The association between the salivary microbiota and pancreatic cancer has been analyzed using the Human Oral Microbe Identification Microarray,<xref ref-type="bibr" rid="CIT0045">45</xref> and two out of six bacterial candidates (<italic>Neisseria elongate</italic> and <italic>Streptococcus mitis</italic>) had significantly lower levels in pancreatic cancer patients than in the control group (<italic>P</italic>&lt;0.05). Another prospective cohort study analyzed 361 patients with incident pancreatic cancer and 371 matched controls and revealed that <italic>Porphyromonas gingivalis</italic> and <italic>Aggregatibacter actinomycetemcomitans</italic> were associated with a higher risk of pancreatic cancer (odds ratio: 2.20, 95% confidence interval: 1.16 to 4.18). In contrast, the genus <italic>Leptotrichia</italic> and its phylum <italic>Fusobacteria</italic> were associated with a lower risk of pancreatic cancer (odds ratio: 0.87, 95% confidence interval: 0.79 to 0.95).<xref ref-type="bibr" rid="CIT0046">46</xref></p>
</sec>
<sec id="S0004">
<title>Gut–lung axis and lung microbiota</title>
<p>Lung cancer is a disease with poor prognosis, and the development of further preventive strategies is important. The concept of the “gut–lung axis” involves immune cells (such as T and B cells) that are activated by the gut microbiota, carried to the lungs by lymphatic or hematogenous spread, activate lung immune cells, and induce respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis and respiratory infection.<xref ref-type="bibr" rid="CIT0047">47</xref>–<xref ref-type="bibr" rid="CIT0050">50</xref></p>
<p>It has been reported that the lung microbiota and oral microbiota are involved in lung carcinogenesis.<xref ref-type="bibr" rid="CIT0051">51</xref>–<xref ref-type="bibr" rid="CIT0053">53</xref> Salivary <italic>Capnocytophaga, Selenomonas, Veillonella</italic> and <italic>Neisseria</italic> were significantly altered in patients with squamous cell carcinoma (n=10) and adenocarcinoma (n=10) compared with control subjects (n=10).<xref ref-type="bibr" rid="CIT0052">52</xref> In another study, although the sample size was small (n=8/group), the bacterial diversity in sputum samples was significantly different between lung cancer patients and control subjects (<italic>P</italic>=0.038).<xref ref-type="bibr" rid="CIT0054">54</xref> Lung cancer cases had more <italic>Granulicatella</italic> (6.1% vs 2.0%; <italic>P</italic>=0.0016), <italic>Abiotrophia</italic> (1.5% vs 0.085%; <italic>P</italic>=0.0036) and <italic>Streptococcus</italic> (40.1 vs 19.8%; <italic>P</italic>=0.0142) than the control subjects.<xref ref-type="bibr" rid="CIT0054">54</xref> Another study revealed that <italic>Granulicatella adiacens</italic> had a higher abundance in sputum samples of four patients with lung cancer compared to six control subjects.<xref ref-type="bibr" rid="CIT0055">55</xref> Analysis of bronchoalveolar lavage fluid (BALF) from 20 patients with lung cancer and eight control subjects revealed that the levels of two phyla (<italic>Firmicutes</italic> and <italic>TM7</italic>) were significantly increased in the patients with lung cancer (<italic>P</italic>=0.037 and 0.035, respectively).<xref ref-type="bibr" rid="CIT0056">56</xref> Moreover, a study analyzed bronchoscopic specimens from 24 patients with lung cancer and 18 healthy controls and revealed that the genus <italic>Streptococcus</italic> was significantly more abundant in the lung cancer patients and, for predicting lung cancer, the area under the curve (AUC) of <italic>Streptococcus</italic> was 0.693 (sensitivity =87.5%, specificity =55.6%).<xref ref-type="bibr" rid="CIT0051">51</xref></p>
</sec>
<sec id="S0005">
<title>Cancer prevention</title>
<p>The following treatment methods are being studied for controlling intestinal bacteria: improvement of gut microbiota dysbiosis, administration of prebiotics, which regulate the gut microbiota, administration of probiotics, which activate T cells, and administration of antibiotics.<xref ref-type="bibr" rid="CIT0057">57</xref> When high-fat diets were administered to <italic>K-ras</italic><sup>G12Dint</sup> mice, tumors were formed in the small intestine, which was due to dysbiosis rather than obesity.<xref ref-type="bibr" rid="CIT0058">58</xref>
<italic>B. fragilis</italic>-specific CD4-positive Th1 cells enhanced the anti-tumor effect of cytotoxic T-lymphocyte antigen (CTLA)-4 antibody.<xref ref-type="bibr" rid="CIT0059">59</xref> In addition, <italic>Bifidobacterium</italic> spp. increased the expression of immune-associated genes on spleen or lymph node dendritic cells and induced anti-tumor CD8-positive cells.<xref ref-type="bibr" rid="CIT0060">60</xref>
<italic>Bifidobacterium lactis</italic> decreased the incidence of colorectal tumor in a mouse model<xref ref-type="bibr" rid="CIT0061">61</xref> and rat model<xref ref-type="bibr" rid="CIT0062">62</xref> of azoxymethane (AOM)-induced colorectal cancer, by inducing apoptosis or suppressing NF-κB signaling. Probiotics consisting of a mixture of <italic>Lactobacillus rhamnosus</italic> GG and <italic>Lactobacillus casei</italic> Shirota suppress the development of aflatoxin-induced liver cancer in rats.<xref ref-type="bibr" rid="CIT0063">63</xref> The probiotic product VSL#3, which is composed of <italic>L. casei, Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus delbrueckii</italic> subsp. <italic>bulgaricus, Bifidobacterium breve, Bifidobacterium longum, Bifidobacterium infantis</italic> and <italic>Streptococcus salivarius</italic> subsp. <italic>thermophilus</italic>, suppressed trinitrobenzene sulfonic acid (TNBS)-induced colitis-related colorectal cancer in rats.<xref ref-type="bibr" rid="CIT0064">64</xref> VSL#3 also suppressed the development of diethylnitrosamine (DEN)-induced liver cancer by improving the gut microbiota and suppressing the release of endotoxin from the intestines to the blood.<xref ref-type="bibr" rid="CIT0065">65</xref> Probiotics consisting of a mixture of VSL#3, <italic>L. rhamnosus</italic> GG and <italic>Escherichia coli</italic> Nissle 1917 suppressed the growth of a xenograft of the liver cancer cell line Hepa1-6 by decreasing Th17 cells and suppressing cytokine production.<xref ref-type="bibr" rid="CIT0066">66</xref> When antibiotics were administered to <italic>Apc</italic><sup>Min/+</sup><italic>Msh2</italic><sup>−/-</sup> mice, the development of colorectal cancer was significantly suppressed.<xref ref-type="bibr" rid="CIT0067">67</xref></p>
</sec>
<sec id="S0006">
<title>Clinical trials of probiotics</title>
<p>A prospective cohort study that followed 45,241 participants for 12 years revealed that participants who ingested yoghurt produced by <italic>Streptococcus thermophilus</italic> and <italic>Lactobacillus delbrueckii</italic> subsp. <italic>bulgaricus</italic> had a lower risk of developing colorectal cancer than participants who did not ingest the yoghurt (hazard ratio: 0.62, 95% confidence interval: 0.46 to 0.83).<xref ref-type="bibr" rid="CIT0068">68</xref> A case-control study comparing 304 female breast cancer patients aged 40–55 years old with 662 subjects matched for age and residential area revealed that those who drank beverages containing <italic>L. casei</italic> Shirota &gt;4 times/week were less likely to experience breast cancer relapse than those who did not (odds ratio: 0.65).<xref ref-type="bibr" rid="CIT0069">69</xref> Moreover, a randomized controlled trial of postoperative bladder cancer patients showed a significantly higher 3-year relapse-free survival rate in the epirubicin plus <italic>L. casei</italic> Shirota group than the epirubicin-only group (74.6% vs 59.9%, <italic>P</italic>=0.0234).<xref ref-type="bibr" rid="CIT0070">70</xref> Patients with colon cancer that received probiotics, <italic>Bifidobacterium lactis</italic> Bl-04 and <italic>Lactobacillus acidophilus</italic> NCFM had an increased abundance of butyrate-producing bacteria, especially <italic>Faecalibacterium</italic> and <italic>Clostridiales</italic> spp in the tumour, non-tumour mucosa and faecal microbiota, resulting in the reduction of colorectal cancer-associated genera such as <italic>Fusobacterium</italic> and <italic>Peptostreptococcus</italic>.<xref ref-type="bibr" rid="CIT0071">71</xref> Recent study showed that a probiotic combination containing <italic>Bifidobacterium infantis, Lactobacillus acidophilus, Enterococcus faecalis</italic> and <italic>Bacillus cereus</italic> reduced the physiological disorders induced by gastrectomy.<xref ref-type="bibr" rid="CIT0072">72</xref> Another randomized, double-blind, placebo-controlled trial showed that probiotics reduced the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma.<xref ref-type="bibr" rid="CIT0073">73</xref> However, in cancer patients and immunosuppressed patients, caution is required because probiotic administration may lead to bacteremia directly caused by the probiotic bacteria.<xref ref-type="bibr" rid="CIT0074">74</xref></p>
</sec>
<sec id="S0007">
<title>Observations and conclusions</title>
<p>Based on the results of animal experiments, probiotics seem to be effective for the prevention of carcinogenesis to some extent. However, there are few randomized controlled trials in humans, and further studies are necessary.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We thank members of Division of Respiratory Medicine at the Kobe University Graduate School of Medicine for their support.</p>
</ack>
<sec id="S0008" sec-type="COI-statement">
<title>Disclosure</title>
<p>Dr Yoshihiro Nishimura reports grants from Eli Lilly Japan K.K. and personal fees from AstraZeneca K.K. outside the submitted work. The authors report no other conflicts of interest in this work.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="CIT0001">
<label>1.</label>
<mixed-citation publication-type="journal"><string-name><surname>Chen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Domingue</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Sears</surname>
<given-names>CL</given-names></string-name>. <article-title>Microbiota dysbiosis in select human cancers: evidence of association and causality</article-title>. <source/><italic toggle="yes">Semin Immunol</italic>. <year>2017</year>;<volume>32</volume>:<fpage>25</fpage>–<lpage>34</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smim.2017.08.001</pub-id><pub-id pub-id-type="pmid">28822617</pub-id></mixed-citation>
</ref>
<ref id="CIT0002">
<label>2.</label>
<mixed-citation publication-type="journal"><string-name><surname>Zhu</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Gao</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Qin</surname>
<given-names>H</given-names></string-name>. <article-title>The role of gut microbiota in the pathogenesis of colorectal cancer</article-title>. <source/><italic toggle="yes">Tumour Biol</italic>. <year>2013</year>;<volume>34</volume>(<issue>3</issue>):<fpage>1285</fpage>–<lpage>1300</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s13277-013-0684-4</pub-id><pub-id pub-id-type="pmid">23397545</pub-id></mixed-citation>
</ref>
<ref id="CIT0003">
<label>3.</label>
<mixed-citation publication-type="journal"><string-name><surname>Clarke</surname>
<given-names>TB</given-names></string-name>. <article-title>Early innate immunity to bacterial infection in the lung is regulated systemically by the commensal microbiota via nod-like receptor ligands</article-title>. <source/><italic toggle="yes">Infect Immun</italic>. <year>2014</year>;<volume>82</volume>(<issue>11</issue>):<fpage>4596</fpage>–<lpage>4606</lpage>. doi:<pub-id pub-id-type="doi">10.1128/IAI.02212-14</pub-id><pub-id pub-id-type="pmid">25135683</pub-id></mixed-citation>
</ref>
<ref id="CIT0004">
<label>4.</label>
<mixed-citation publication-type="journal"><string-name><surname>Ivanov</surname>
<given-names>II</given-names></string-name>, <string-name><surname>Atarashi</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Manel</surname>
<given-names>N</given-names></string-name>, et al. <article-title>Induction of intestinal Th17 cells by segmented filamentous bacteria</article-title>. <source/><italic toggle="yes">Cell</italic>. <year>2009</year>;<volume>139</volume>(<issue>3</issue>):<fpage>485</fpage>–<lpage>498</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2009.09.033</pub-id><pub-id pub-id-type="pmid">19836068</pub-id></mixed-citation>
</ref>
<ref id="CIT0005">
<label>5.</label>
<mixed-citation publication-type="journal"><string-name><surname>Atarashi</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Tanoue</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Ando</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Th17 cell induction by adhesion of microbes to intestinal epithelial cells</article-title>. <source/><italic toggle="yes">Cell</italic>. <year>2015</year>;<volume>163</volume>(<issue>2</issue>):<fpage>367</fpage>–<lpage>380</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2015.08.058</pub-id><pub-id pub-id-type="pmid">26411289</pub-id></mixed-citation>
</ref>
<ref id="CIT0006">
<label>6.</label>
<mixed-citation publication-type="journal"><string-name><surname>Atarashi</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Tanoue</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Shima</surname>
<given-names>T</given-names></string-name>, et al. <article-title>Induction of colonic regulatory T cells by indigenous Clostridium species</article-title>. <source/><italic toggle="yes">Science</italic>. <year>2011</year>;<volume>331</volume>(<issue>6015</issue>):<fpage>337</fpage>–<lpage>341</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1198469</pub-id><pub-id pub-id-type="pmid">21205640</pub-id></mixed-citation>
</ref>
<ref id="CIT0007">
<label>7.</label>
<mixed-citation publication-type="journal"><string-name><surname>Atarashi</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Tanoue</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Oshima</surname>
<given-names>K</given-names></string-name>, et al. <article-title>Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota</article-title>. <source/><italic toggle="yes">Nature</italic>. <year>2013</year>;<volume>500</volume>(<issue>7461</issue>):<fpage>232</fpage>–<lpage>236</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature12331</pub-id><pub-id pub-id-type="pmid">23842501</pub-id></mixed-citation>
</ref>
<ref id="CIT0008">
<label>8.</label>
<mixed-citation publication-type="journal"><string-name><surname>Furusawa</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Obata</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Fukuda</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells</article-title>. <source/><italic toggle="yes">Nature</italic>. <year>2013</year>;<volume>504</volume>(<issue>7480</issue>):<fpage>446</fpage>–<lpage>450</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature12721</pub-id><pub-id pub-id-type="pmid">24226770</pub-id></mixed-citation>
</ref>
<ref id="CIT0009">
<label>9.</label>
<mixed-citation publication-type="journal"><string-name><surname>Kimura</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Inoue</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Maeda</surname>
<given-names>T</given-names></string-name>, et al. <article-title>Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41)</article-title>. <source/><italic toggle="yes">Proc Natl Acad Sci U S A</italic>. <year>2011</year>;<volume>108</volume>(<issue>19</issue>):<fpage>8030</fpage>–<lpage>8035</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1016088108</pub-id><pub-id pub-id-type="pmid">21518883</pub-id></mixed-citation>
</ref>
<ref id="CIT0010">
<label>10.</label>
<mixed-citation publication-type="journal"><string-name><surname>Honda</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Littman</surname>
<given-names>DR</given-names></string-name>. <article-title>The microbiome in infectious disease and inflammation</article-title>. <source/><italic toggle="yes">Annu Rev Immunol</italic>. <year>2012</year>;<volume>30</volume>:<fpage>759</fpage>–<lpage>795</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev-immunol-020711-074937</pub-id><pub-id pub-id-type="pmid">22224764</pub-id></mixed-citation>
</ref>
<ref id="CIT0011">
<label>11.</label>
<mixed-citation publication-type="journal"><string-name><surname>Hooper</surname>
<given-names>LV</given-names></string-name>, <string-name><surname>Littman</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Macpherson</surname>
<given-names>AJ</given-names></string-name>. <article-title>Interactions between the microbiota and the immune system</article-title>. <source/><italic toggle="yes">Science</italic>. <year>2012</year>;<volume>336</volume>(<issue>6086</issue>):<fpage>1268</fpage>–<lpage>1273</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1223490</pub-id><pub-id pub-id-type="pmid">22674334</pub-id></mixed-citation>
</ref>
<ref id="CIT0012">
<label>12.</label>
<mixed-citation publication-type="journal"><string-name><surname>Abt</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Artis</surname>
<given-names>D</given-names></string-name>. <article-title>The dynamic influence of commensal bacteria on the immune response to pathogens</article-title>. <source/><italic toggle="yes">Curr Opin Microbiol</italic>. <year>2013</year>;<volume>16</volume>(<issue>1</issue>):<fpage>4</fpage>–<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mib.2012.12.002</pub-id><pub-id pub-id-type="pmid">23332724</pub-id></mixed-citation>
</ref>
<ref id="CIT0013">
<label>13.</label>
<mixed-citation publication-type="journal"><string-name><surname>Berer</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Krishnamoorthy</surname>
<given-names>G</given-names></string-name>. <article-title>Microbial view of central nervous system autoimmunity</article-title>. <source/><italic toggle="yes">FEBS Lett</italic>. <year>2014</year>;<volume>588</volume>(<issue>22</issue>):<fpage>4207</fpage>–<lpage>4213</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.febslet.2014.04.007</pub-id><pub-id pub-id-type="pmid">24746689</pub-id></mixed-citation>
</ref>
<ref id="CIT0014">
<label>14.</label>
<mixed-citation publication-type="journal"><string-name><surname>Chu</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Mazmanian</surname>
<given-names>SK</given-names></string-name>. <article-title>Innate immune recognition of the microbiota promotes host-microbial symbiosis</article-title>. <source/><italic toggle="yes">Nat Immunol</italic>. <year>2013</year>;<volume>14</volume>(<issue>7</issue>):<fpage>668</fpage>–<lpage>675</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ni.2635</pub-id><pub-id pub-id-type="pmid">23778794</pub-id></mixed-citation>
</ref>
<ref id="CIT0015">
<label>15.</label>
<mixed-citation publication-type="journal"><string-name><surname>Erturk-Hasdemir</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Kasper</surname>
<given-names>DL</given-names></string-name>. <article-title>Resident commensals shaping immunity</article-title>. <source/><italic toggle="yes">Curr Opin Immunol</italic>. <year>2013</year>;<volume>25</volume>(<issue>4</issue>):<fpage>450</fpage>–<lpage>455</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.coi.2013.06.001</pub-id><pub-id pub-id-type="pmid">23830047</pub-id></mixed-citation>
</ref>
<ref id="CIT0016">
<label>16.</label>
<mixed-citation publication-type="journal"><string-name><surname>Iida</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Dzutsev</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Stewart</surname>
<given-names>CA</given-names></string-name>, et al. <article-title>Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment</article-title>. <source/><italic toggle="yes">Science</italic>. <year>2013</year>;<volume>342</volume>(<issue>6161</issue>):<fpage>967</fpage>–<lpage>970</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1240527</pub-id><pub-id pub-id-type="pmid">24264989</pub-id></mixed-citation>
</ref>
<ref id="CIT0017">
<label>17.</label>
<mixed-citation publication-type="journal"><string-name><surname>Khosravi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Mazmanian</surname>
<given-names>SK</given-names></string-name>. <article-title>Disruption of the gut microbiome as a risk factor for microbial infections</article-title>. <source/><italic toggle="yes">Curr Opin Microbiol</italic>. <year>2013</year>;<volume>16</volume>(<issue>2</issue>):<fpage>221</fpage>–<lpage>227</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mib.2013.03.009</pub-id><pub-id pub-id-type="pmid">23597788</pub-id></mixed-citation>
</ref>
<ref id="CIT0018">
<label>18.</label>
<mixed-citation publication-type="journal"><string-name><surname>Molloy</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Bouladoux</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Belkaid</surname>
<given-names>Y</given-names></string-name>. <article-title>Intestinal microbiota: shaping local and systemic immune responses</article-title>. <source/><italic toggle="yes">Semin Immunol</italic>. <year>2012</year>;<volume>24</volume>(<issue>1</issue>):<fpage>58</fpage>–<lpage>66</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smim.2011.11.008</pub-id><pub-id pub-id-type="pmid">22178452</pub-id></mixed-citation>
</ref>
<ref id="CIT0019">
<label>19.</label>
<mixed-citation publication-type="journal"><string-name><surname>Naik</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Bouladoux</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Wilhelm</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Compartmentalized control of skin immunity by resident commensals</article-title>. <source/><italic toggle="yes">Science</italic>. <year>2012</year>;<volume>337</volume>(<issue>6098</issue>):<fpage>1115</fpage>–<lpage>1119</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1225152</pub-id><pub-id pub-id-type="pmid">22837383</pub-id></mixed-citation>
</ref>
<ref id="CIT0020">
<label>20.</label>
<mixed-citation publication-type="journal"><string-name><surname>Rakoff-Nahoum</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Medzhitov</surname>
<given-names>R</given-names></string-name>. <article-title>Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88</article-title>. <source/><italic toggle="yes">Science</italic>. <year>2007</year>;<volume>317</volume>(<issue>5834</issue>):<fpage>124</fpage>–<lpage>127</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1140488</pub-id><pub-id pub-id-type="pmid">17615359</pub-id></mixed-citation>
</ref>
<ref id="CIT0021">
<label>21.</label>
<mixed-citation publication-type="journal"><string-name><surname>Round</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Mazmanian</surname>
<given-names>SK</given-names></string-name>. <article-title>The gut microbiota shapes intestinal immune responses during health and disease</article-title>. <source/><italic toggle="yes">Nat Rev Immunol</italic>. <year>2009</year>;<volume>9</volume>(<issue>5</issue>):<fpage>313</fpage>–<lpage>323</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nri2515</pub-id><pub-id pub-id-type="pmid">19343057</pub-id></mixed-citation>
</ref>
<ref id="CIT0022">
<label>22.</label>
<mixed-citation publication-type="journal"><string-name><surname>Wu</surname>
<given-names>HJ</given-names></string-name>, <string-name><surname>Ivanov</surname>
<given-names>II</given-names></string-name>, <string-name><surname>Darce</surname>
<given-names>J</given-names></string-name>, et al. <article-title>Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells</article-title>. <source/><italic toggle="yes">Immunity</italic>. <year>2010</year>;<volume>32</volume>(<issue>6</issue>):<fpage>815</fpage>–<lpage>827</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.immuni.2010.06.001</pub-id><pub-id pub-id-type="pmid">20620945</pub-id></mixed-citation>
</ref>
<ref id="CIT0023">
<label>23.</label>
<mixed-citation publication-type="journal"><string-name><surname>Rakoff-Nahoum</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Hao</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Medzhitov</surname>
<given-names>R</given-names></string-name>. <article-title>Role of toll-like receptors in spontaneous commensal-dependent colitis</article-title>. <source/><italic toggle="yes">Immunity</italic>. <year>2006</year>;<volume>25</volume>(<issue>2</issue>):<fpage>319</fpage>–<lpage>329</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.immuni.2006.06.010</pub-id><pub-id pub-id-type="pmid">16879997</pub-id></mixed-citation>
</ref>
<ref id="CIT0024">
<label>24.</label>
<mixed-citation publication-type="journal"><string-name><surname>Abt</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Osborne</surname>
<given-names>LC</given-names></string-name>, <string-name><surname>Monticelli</surname>
<given-names>LA</given-names></string-name>, et al. <article-title>Commensal bacteria calibrate the activation threshold of innate antiviral immunity</article-title>. <source/><italic toggle="yes">Immunity</italic>. <year>2012</year>;<volume>37</volume>(<issue>1</issue>):<fpage>158</fpage>–<lpage>170</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.immuni.2012.04.011</pub-id><pub-id pub-id-type="pmid">22705104</pub-id></mixed-citation>
</ref>
<ref id="CIT0025">
<label>25.</label>
<mixed-citation publication-type="journal"><string-name><surname>Brandl</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Plitas</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Mihu</surname>
<given-names>CN</given-names></string-name>, et al. <article-title>Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits</article-title>. <source/><italic toggle="yes">Nature</italic>. <year>2008</year>;<volume>455</volume>(<issue>7214</issue>):<fpage>804</fpage>–<lpage>807</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature07250</pub-id><pub-id pub-id-type="pmid">18724361</pub-id></mixed-citation>
</ref>
<ref id="CIT0026">
<label>26.</label>
<mixed-citation publication-type="journal"><string-name><surname>Deshmukh</surname>
<given-names>HS</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Menkiti</surname>
<given-names>OR</given-names></string-name>, et al. <article-title>The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice</article-title>. <source/><italic toggle="yes">Nat Med</italic>. <year>2014</year>;<volume>20</volume>(<issue>5</issue>):<fpage>524</fpage>–<lpage>530</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nm.3542</pub-id><pub-id pub-id-type="pmid">24747744</pub-id></mixed-citation>
</ref>
<ref id="CIT0027">
<label>27.</label>
<mixed-citation publication-type="journal"><string-name><surname>Didierlaurent</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Goulding</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Patel</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection</article-title>. <source/><italic toggle="yes">J Exp Med</italic>. <year>2008</year>;<volume>205</volume>(<issue>2</issue>):<fpage>323</fpage>–<lpage>329</lpage>. doi:<pub-id pub-id-type="doi">10.1084/jem.20070891</pub-id><pub-id pub-id-type="pmid">18227219</pub-id></mixed-citation>
</ref>
<ref id="CIT0028">
<label>28.</label>
<mixed-citation publication-type="journal"><string-name><surname>Duarte</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Silva</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Vieira</surname>
<given-names>LQ</given-names></string-name>, <string-name><surname>Afonso</surname>
<given-names>LC</given-names></string-name>, <string-name><surname>Nicoli</surname>
<given-names>JR</given-names></string-name>. <article-title>Influence of normal microbiota on some aspects of the immune response during experimental infection with Trypanosoma cruzi in mice</article-title>. <source/><italic toggle="yes">J Med Microbiol</italic>. <year>2004</year>;<volume>53</volume>(<issue>Pt 8</issue>):<fpage>741</fpage>–<lpage>748</lpage>. doi:<pub-id pub-id-type="doi">10.1099/jmm.0.45657-0</pub-id><pub-id pub-id-type="pmid">15272060</pub-id></mixed-citation>
</ref>
<ref id="CIT0029">
<label>29.</label>
<mixed-citation publication-type="journal"><string-name><surname>Fagundes</surname>
<given-names>CT</given-names></string-name>, <string-name><surname>Amaral</surname>
<given-names>FA</given-names></string-name>, <string-name><surname>Vieira</surname>
<given-names>AT</given-names></string-name>, et al. <article-title>Transient TLR activation restores inflammatory response and ability to control pulmonary bacterial infection in germfree mice</article-title>. <source/><italic toggle="yes">J Immunol</italic>. <year>2012</year>;<volume>188</volume>(<issue>3</issue>):<fpage>1411</fpage>–<lpage>1420</lpage>. doi:<pub-id pub-id-type="doi">10.4049/jimmunol.1101682</pub-id><pub-id pub-id-type="pmid">22210917</pub-id></mixed-citation>
</ref>
<ref id="CIT0030">
<label>30.</label>
<mixed-citation publication-type="journal"><string-name><surname>Ganal</surname>
<given-names>SC</given-names></string-name>, <string-name><surname>Sanos</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Kallfass</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota</article-title>. <source/><italic toggle="yes">Immunity</italic>. <year>2012</year>;<volume>37</volume>(<issue>1</issue>):<fpage>171</fpage>–<lpage>186</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.immuni.2012.05.020</pub-id><pub-id pub-id-type="pmid">22749822</pub-id></mixed-citation>
</ref>
<ref id="CIT0031">
<label>31.</label>
<mixed-citation publication-type="journal"><string-name><surname>Inagaki</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Suzuki</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Nomoto</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Yoshikai</surname>
<given-names>Y</given-names></string-name>. <article-title>Increased susceptibility to primary infection with Listeria monocytogenes in germfree mice may be due to lack of accumulation of L-selectin+ CD44+ T cells in sites of inflammation</article-title>. <source/><italic toggle="yes">Infect Immun</italic>. <year>1996</year>;<volume>64</volume>(<issue>8</issue>):<fpage>3280</fpage>–<lpage>3287</lpage>.<pub-id pub-id-type="pmid">8757865</pub-id></mixed-citation>
</ref>
<ref id="CIT0032">
<label>32.</label>
<mixed-citation publication-type="journal"><string-name><surname>Khosravi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Yáñez</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Price</surname>
<given-names>JG</given-names></string-name>, et al. <article-title>Gut microbiota promote hematopoiesis to control bacterial infection</article-title>. <source/><italic toggle="yes">Cell Host Microbe</italic>. <year>2014</year>;<volume>15</volume>(<issue>3</issue>):<fpage>374</fpage>–<lpage>381</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chom.2014.02.006</pub-id><pub-id pub-id-type="pmid">24629343</pub-id></mixed-citation>
</ref>
<ref id="CIT0033">
<label>33.</label>
<mixed-citation publication-type="journal"><string-name><surname>Lofgren</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Whary</surname>
<given-names>MT</given-names></string-name>, <string-name><surname>Ge</surname>
<given-names>Z</given-names></string-name>, et al. <article-title>Lack of commensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia</article-title>. <source/><italic toggle="yes">Gastroenterology</italic>. <year>2011</year>;<volume>140</volume>(<issue>1</issue>):<fpage>210</fpage>–<lpage>220</lpage>. doi:<pub-id pub-id-type="doi">10.1053/j.gastro.2010.09.048</pub-id><pub-id pub-id-type="pmid">20950613</pub-id></mixed-citation>
</ref>
<ref id="CIT0034">
<label>34.</label>
<mixed-citation publication-type="journal"><string-name><surname>Baxter</surname>
<given-names>NT</given-names></string-name>, <string-name><surname>Zackular</surname>
<given-names>JP</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>GY</given-names></string-name>, <string-name><surname>Schloss</surname>
<given-names>PD</given-names></string-name>. <article-title>Structure of the gut microbiome following colonization with human feces determines colonic tumor burden</article-title>. <source/><italic toggle="yes">Microbiome</italic>. <year>2014</year>;<volume>2</volume>:<fpage>20</fpage>. doi:<pub-id pub-id-type="doi">10.1186/2049-2618-2-20</pub-id><pub-id pub-id-type="pmid">24967088</pub-id></mixed-citation>
</ref>
<ref id="CIT0035">
<label>35.</label>
<mixed-citation publication-type="journal"><string-name><surname>Van Raay</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Allen-Vercoe</surname>
<given-names>E</given-names></string-name>. <article-title>Microbial Interactions and Interventions in Colorectal Cancer</article-title>. <source/><italic toggle="yes">Microbiol Spectr</italic>. <year>2017</year>;<volume>5</volume>(<issue>3</issue>).</mixed-citation>
</ref>
<ref id="CIT0036">
<label>36.</label>
<mixed-citation publication-type="journal"><string-name><surname>Sears</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Islam</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Saha</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea</article-title>. <source/><italic toggle="yes">Clin Infect Dis</italic>. <year>2008</year>;<volume>47</volume>(<issue>6</issue>):<fpage>797</fpage>–<lpage>803</lpage>. doi:<pub-id pub-id-type="doi">10.1086/591130</pub-id><pub-id pub-id-type="pmid">18680416</pub-id></mixed-citation>
</ref>
<ref id="CIT0037">
<label>37.</label>
<mixed-citation publication-type="journal"><string-name><surname>Guo</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>B</given-names></string-name>, et al. <article-title>A simple and novel fecal biomarker for colorectal cancer: ratio of</article-title>. <source/><italic toggle="yes">Clin Chem</italic>. <year>2018</year>;<volume>64</volume>(<issue>9</issue>):<fpage>1327</fpage>–<lpage>1337</lpage>. doi:<pub-id pub-id-type="doi">10.1373/clinchem.2018.289728</pub-id><pub-id pub-id-type="pmid">29914865</pub-id></mixed-citation>
</ref>
<ref id="CIT0038">
<label>38.</label>
<mixed-citation publication-type="journal"><string-name><surname>Brennan</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Garrett</surname>
<given-names>WS</given-names></string-name>. <article-title>Fusobacterium nucleatum - symbiont, opportunist and oncobacterium</article-title>. <source/><italic toggle="yes">Nat Rev Microbiol</italic>. <year>2019</year>;<volume>17</volume>(<issue>3</issue>):<fpage>156</fpage>–<lpage>166</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41579-018-0129-6</pub-id><pub-id pub-id-type="pmid">30546113</pub-id></mixed-citation>
</ref>
<ref id="CIT0039">
<label>39.</label>
<mixed-citation publication-type="journal"><string-name><surname>Louis</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Hold</surname>
<given-names>GL</given-names></string-name>, <string-name><surname>Flint</surname>
<given-names>HJ</given-names></string-name>. <article-title>The gut microbiota, bacterial metabolites and colorectal cancer</article-title>. <source/><italic toggle="yes">Nat Rev Microbiol</italic>. <year>2014</year>;<volume>12</volume>(<issue>10</issue>):<fpage>661</fpage>–<lpage>672</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrmicro3344</pub-id><pub-id pub-id-type="pmid">25198138</pub-id></mixed-citation>
</ref>
<ref id="CIT0040">
<label>40.</label>
<mixed-citation publication-type="journal"><string-name><surname>Yoshimoto</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Loo</surname>
<given-names>TM</given-names></string-name>, <string-name><surname>Atarashi</surname>
<given-names>K</given-names></string-name>, et al. <article-title>Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome</article-title>. <source/><italic toggle="yes">Nature</italic>. <year>2013</year>;<volume>499</volume>(<issue>7456</issue>):<fpage>97</fpage>–<lpage>101</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature12347</pub-id><pub-id pub-id-type="pmid">23803760</pub-id></mixed-citation>
</ref>
<ref id="CIT0041">
<label>41.</label>
<mixed-citation publication-type="journal"><string-name><surname>Loo</surname>
<given-names>TM</given-names></string-name>, <string-name><surname>Kamachi</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Watanabe</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>Gut microbiota promotes obesity-associated liver cancer through PGE</article-title>. <source/><italic toggle="yes">Cancer Discov</italic>. <year>2017</year>;<volume>7</volume>(<issue>5</issue>):<fpage>522</fpage>–<lpage>538</lpage>. doi:<pub-id pub-id-type="doi">10.1158/2159-8290.CD-16-0932</pub-id><pub-id pub-id-type="pmid">28202625</pub-id></mixed-citation>
</ref>
<ref id="CIT0042">
<label>42.</label>
<mixed-citation publication-type="journal"><string-name><surname>Okumura</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Yamagishi</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Nukui</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Nakao</surname>
<given-names>K</given-names></string-name>. <article-title>Discovery of AAT-008, a novel, potent, and selective prostaglandin EP4 receptor antagonist</article-title>. <source/><italic toggle="yes">Bioorg Med Chem Lett</italic>. <year>2017</year>;<volume>27</volume>(<issue>5</issue>):<fpage>1186</fpage>–<lpage>1192</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bmcl.2017.01.067</pub-id><pub-id pub-id-type="pmid">28169162</pub-id></mixed-citation>
</ref>
<ref id="CIT0043">
<label>43.</label>
<mixed-citation publication-type="journal"><string-name><surname>Bajic</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Wolfe</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Gupta</surname>
<given-names>GN</given-names></string-name>. <article-title>The Urinary Microbiome: implications in Bladder Cancer Pathogenesis and Therapeutics</article-title>. <source/><italic toggle="yes">Urology</italic>. <year>2019</year>.</mixed-citation>
</ref>
<ref id="CIT0044">
<label>44.</label>
<mixed-citation publication-type="journal"><string-name><surname>Dewhirst</surname>
<given-names>FE</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Izard</surname>
<given-names>J</given-names></string-name>, et al. <article-title>The human oral microbiome</article-title>. <source/><italic toggle="yes">J Bacteriol</italic>. <year>2010</year>;<volume>192</volume>(<issue>19</issue>):<fpage>5002</fpage>–<lpage>5017</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JB.00542-10</pub-id><pub-id pub-id-type="pmid">20656903</pub-id></mixed-citation>
</ref>
<ref id="CIT0045">
<label>45.</label>
<mixed-citation publication-type="journal"><string-name><surname>Farrell</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>H</given-names></string-name>, et al. <article-title>Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer</article-title>. <source/><italic toggle="yes">Gut</italic>. <year>2012</year>;<volume>61</volume>(<issue>4</issue>):<fpage>582</fpage>–<lpage>588</lpage>. doi:<pub-id pub-id-type="doi">10.1136/gutjnl-2011-300784</pub-id><pub-id pub-id-type="pmid">21994333</pub-id></mixed-citation>
</ref>
<ref id="CIT0046">
<label>46.</label>
<mixed-citation publication-type="journal"><string-name><surname>Fan</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Alekseyenko</surname>
<given-names>AV</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>J</given-names></string-name>, et al. <article-title>Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study</article-title>. <source/><italic toggle="yes">Gut</italic>. <year>2018</year>;<volume>67</volume>(<issue>1</issue>):<fpage>120</fpage>–<lpage>127</lpage>. doi:<pub-id pub-id-type="doi">10.1136/gutjnl-2016-312580</pub-id><pub-id pub-id-type="pmid">27742762</pub-id></mixed-citation>
</ref>
<ref id="CIT0047">
<label>47.</label>
<mixed-citation publication-type="journal"><string-name><surname>Bingula</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Filaire</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Radosevic-Robin</surname>
<given-names>N</given-names></string-name>, et al. <article-title>Desired turbulence? Gut-lung axis, immunity, and lung cancer</article-title>. <source/><italic toggle="yes">J Oncol</italic>. <year>2017</year>;<volume>2017</volume>:<fpage>5035371</fpage>. doi:<pub-id pub-id-type="doi">10.1155/2017/5035371</pub-id><pub-id pub-id-type="pmid">29075294</pub-id></mixed-citation>
</ref>
<ref id="CIT0048">
<label>48.</label>
<mixed-citation publication-type="journal"><string-name><surname>Budden</surname>
<given-names>KF</given-names></string-name>, <string-name><surname>Gellatly</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Wood</surname>
<given-names>DL</given-names></string-name>, et al. <article-title>Emerging pathogenic links between microbiota and the gut-lung axis</article-title>. <source/><italic toggle="yes">Nat Rev Microbiol</italic>. <year>2017</year>;<volume>15</volume>(<issue>1</issue>):<fpage>55</fpage>–<lpage>63</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrmicro.2016.142</pub-id><pub-id pub-id-type="pmid">27694885</pub-id></mixed-citation>
</ref>
<ref id="CIT0049">
<label>49.</label>
<mixed-citation publication-type="journal"><string-name><surname>Marsland</surname>
<given-names>BJ</given-names></string-name>, <string-name><surname>Trompette</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Gollwitzer</surname>
<given-names>ES</given-names></string-name>. <article-title>The gut-lung axis in respiratory disease</article-title>. <source/><italic toggle="yes">Ann Am Thorac Soc</italic>. <year>2015</year>;<volume>12</volume>(<issue>Suppl 2</issue>):<fpage>S150</fpage>–<lpage>S156</lpage>. doi:<pub-id pub-id-type="doi">10.1513/AnnalsATS.201503-133AW</pub-id><pub-id pub-id-type="pmid">26595731</pub-id></mixed-citation>
</ref>
<ref id="CIT0050">
<label>50.</label>
<mixed-citation publication-type="journal"><string-name><surname>Shukla</surname>
<given-names>SD</given-names></string-name>, <string-name><surname>Budden</surname>
<given-names>KF</given-names></string-name>, <string-name><surname>Neal</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Hansbro</surname>
<given-names>PM</given-names></string-name>. <article-title>Microbiome effects on immunity, health and disease in the lung</article-title>. <source/><italic toggle="yes">Clin Transl Immunol</italic>. <year>2017</year>;<volume>6</volume>(<issue>3</issue>):<fpage>e133</fpage>. doi:<pub-id pub-id-type="doi">10.1038/cti.2017.6</pub-id></mixed-citation>
</ref>
<ref id="CIT0051">
<label>51.</label>
<mixed-citation publication-type="journal"><string-name><surname>Liu</surname>
<given-names>HX</given-names></string-name>, <string-name><surname>Tao</surname>
<given-names>LL</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>J</given-names></string-name>, et al. <article-title>Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects</article-title>. <source/><italic toggle="yes">Int J Cancer</italic>. <year>2018</year>;<volume>142</volume>(<issue>4</issue>):<fpage>769</fpage>–<lpage>778</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ijc.31098</pub-id><pub-id pub-id-type="pmid">29023689</pub-id></mixed-citation>
</ref>
<ref id="CIT0052">
<label>52.</label>
<mixed-citation publication-type="journal"><string-name><surname>Yan</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>J</given-names></string-name>, et al. <article-title>Discovery and validation of potential bacterial biomarkers for lung cancer</article-title>. <source/><italic toggle="yes">Am J Cancer Res</italic>. <year>2015</year>;<volume>5</volume>(<issue>10</issue>):<fpage>3111</fpage>–<lpage>3122</lpage>.<pub-id pub-id-type="pmid">26693063</pub-id></mixed-citation>
</ref>
<ref id="CIT0053">
<label>53.</label>
<mixed-citation publication-type="journal"><string-name><surname>Mao</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Jiang</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Yin</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Interplay between the lung microbiome and lung cancer</article-title>. <source/><italic toggle="yes">Cancer Lett</italic>. <year>2018</year>;<volume>415</volume>:<fpage>40</fpage>–<lpage>48</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.canlet.2017.11.036</pub-id><pub-id pub-id-type="pmid">29197615</pub-id></mixed-citation>
</ref>
<ref id="CIT0054">
<label>54.</label>
<mixed-citation publication-type="journal"><string-name><surname>Hosgood</surname>
<given-names>HD</given-names></string-name>, <string-name><surname>Sapkota</surname>
<given-names>AR</given-names></string-name>, <string-name><surname>Rothman</surname>
<given-names>N</given-names></string-name>, et al. <article-title>The potential role of lung microbiota in lung cancer attributed to household coal burning exposures</article-title>. <source/><italic toggle="yes">Environ Mol Mutagen</italic>. <year>2014</year>;<volume>55</volume>(<issue>8</issue>):<fpage>643</fpage>–<lpage>651</lpage>. doi:<pub-id pub-id-type="doi">10.1002/em.21878</pub-id><pub-id pub-id-type="pmid">24895247</pub-id></mixed-citation>
</ref>
<ref id="CIT0055">
<label>55.</label>
<mixed-citation publication-type="journal"><string-name><surname>Cameron</surname>
<given-names>SJS</given-names></string-name>, <string-name><surname>Lewis</surname>
<given-names>KE</given-names></string-name>, <string-name><surname>Huws</surname>
<given-names>SA</given-names></string-name>, et al. <article-title>A pilot study using metagenomic sequencing of the sputum microbiome suggests potential bacterial biomarkers for lung cancer</article-title>. <source/><italic toggle="yes">PLoS One</italic>. <year>2017</year>;<volume>12</volume>(<issue>5</issue>):<fpage>e0177062</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0177062</pub-id><pub-id pub-id-type="pmid">28542458</pub-id></mixed-citation>
</ref>
<ref id="CIT0056">
<label>56.</label>
<mixed-citation publication-type="journal"><string-name><surname>Lee</surname>
<given-names>SH</given-names></string-name>, <string-name><surname>Sung</surname>
<given-names>JY</given-names></string-name>, <string-name><surname>Yong</surname>
<given-names>D</given-names></string-name>, et al. <article-title>Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions</article-title>. <source/><italic toggle="yes">Lung Cancer</italic>. <year>2016</year>;<volume>102</volume>:<fpage>89</fpage>–<lpage>95</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.lungcan.2016.10.016</pub-id><pub-id pub-id-type="pmid">27987594</pub-id></mixed-citation>
</ref>
<ref id="CIT0057">
<label>57.</label>
<mixed-citation publication-type="journal"><string-name><surname>Pitt</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Vétizou</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Daillère</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Resistance mechanisms to immune-checkpoint blockade in cancer: tumor-intrinsic and -extrinsic factors</article-title>. <source/><italic toggle="yes">Immunity</italic>. <year>2016</year>;<volume>44</volume>(<issue>6</issue>):<fpage>1255</fpage>–<lpage>1269</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.immuni.2016.06.001</pub-id><pub-id pub-id-type="pmid">27332730</pub-id></mixed-citation>
</ref>
<ref id="CIT0058">
<label>58.</label>
<mixed-citation publication-type="journal"><string-name><surname>Schulz</surname>
<given-names>MD</given-names></string-name>, <string-name><surname>Atay</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Heringer</surname>
<given-names>J</given-names></string-name>, et al. <article-title>High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity</article-title>. <source/><italic toggle="yes">Nature</italic>. <year>2014</year>;<volume>514</volume>(<issue>7523</issue>):<fpage>508</fpage>–<lpage>512</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature13398</pub-id><pub-id pub-id-type="pmid">25174708</pub-id></mixed-citation>
</ref>
<ref id="CIT0059">
<label>59.</label>
<mixed-citation publication-type="journal"><string-name><surname>Vétizou</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Pitt</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Daillère</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota</article-title>. <source/><italic toggle="yes">Science</italic>. <year>2015</year>;<volume>350</volume>(<issue>6264</issue>):<fpage>1079</fpage>–<lpage>1084</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.aad1329</pub-id><pub-id pub-id-type="pmid">26541610</pub-id></mixed-citation>
</ref>
<ref id="CIT0060">
<label>60.</label>
<mixed-citation publication-type="journal"><string-name><surname>Sivan</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Corrales</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Hubert</surname>
<given-names>N</given-names></string-name>, et al. <article-title>Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy</article-title>. <source/><italic toggle="yes">Science</italic>. <year>2015</year>;<volume>350</volume>(<issue>6264</issue>):<fpage>1084</fpage>–<lpage>1089</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.aac4255</pub-id><pub-id pub-id-type="pmid">26541606</pub-id></mixed-citation>
</ref>
<ref id="CIT0061">
<label>61.</label>
<mixed-citation publication-type="journal"><string-name><surname>Kim</surname>
<given-names>SW</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>HM</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>KM</given-names></string-name>, et al. <article-title>Bifidobacterium lactis inhibits NF-kappaB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice</article-title>. <source/><italic toggle="yes">Inflamm Bowel Dis</italic>. <year>2010</year>;<volume>16</volume>(<issue>9</issue>):<fpage>1514</fpage>–<lpage>1525</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ibd.21262</pub-id><pub-id pub-id-type="pmid">20310012</pub-id></mixed-citation>
</ref>
<ref id="CIT0062">
<label>62.</label>
<mixed-citation publication-type="journal"><string-name><surname>Le Leu</surname>
<given-names>RK</given-names></string-name>, <string-name><surname>Brown</surname>
<given-names>IL</given-names></string-name>, <string-name><surname>Hu</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>A synbiotic combination of resistant starch and Bifidobacterium lactis facilitates apoptotic deletion of carcinogen-damaged cells in rat colon</article-title>. <source/><italic toggle="yes">J Nutr</italic>. <year>2005</year>;<volume>135</volume>(<issue>5</issue>):<fpage>996</fpage>–<lpage>1001</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jn/135.5.996</pub-id><pub-id pub-id-type="pmid">15867271</pub-id></mixed-citation>
</ref>
<ref id="CIT0063">
<label>63.</label>
<mixed-citation publication-type="journal"><string-name><surname>Kumar</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Verma</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Nagpal</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Effect of probiotic fermented milk and chlorophyllin on gene expressions and genotoxicity during AFB₁-induced hepatocellular carcinoma</article-title>. <source/><italic toggle="yes">Gene</italic>. <year>2011</year>;<volume>490</volume>(<issue>1–2</issue>):<fpage>54</fpage>–<lpage>59</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.gene.2011.09.003</pub-id><pub-id pub-id-type="pmid">21963996</pub-id></mixed-citation>
</ref>
<ref id="CIT0064">
<label>64.</label>
<mixed-citation publication-type="journal"><string-name><surname>Appleyard</surname>
<given-names>CB</given-names></string-name>, <string-name><surname>Cruz</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>Isidro</surname>
<given-names>AA</given-names></string-name>, <string-name><surname>Arthur</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Jobin</surname>
<given-names>C</given-names></string-name>, <string-name><surname>De Simone</surname>
<given-names>C</given-names></string-name>. <article-title>Pretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer</article-title>. <source/><italic toggle="yes">Am J Physiol Gastrointest Liver Physiol</italic>. <year>2011</year>;<volume>301</volume>(<issue>6</issue>):<fpage>G1004</fpage>–<lpage>G1013</lpage>. doi:<pub-id pub-id-type="doi">10.1152/ajpgi.00167.2011</pub-id><pub-id pub-id-type="pmid">21903764</pub-id></mixed-citation>
</ref>
<ref id="CIT0065">
<label>65.</label>
<mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>
<given-names>HL</given-names></string-name>, <string-name><surname>Yu</surname>
<given-names>LX</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>W</given-names></string-name>, et al. <article-title>Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats</article-title>. <source/><italic toggle="yes">J Hepatol</italic>. <year>2012</year>;<volume>57</volume>(<issue>4</issue>):<fpage>803</fpage>–<lpage>812</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jhep.2012.06.011</pub-id><pub-id pub-id-type="pmid">22727732</pub-id></mixed-citation>
</ref>
<ref id="CIT0066">
<label>66.</label>
<mixed-citation publication-type="journal"><string-name><surname>Li</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Sung</surname>
<given-names>CY</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>N</given-names></string-name>, et al. <article-title>Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice</article-title>. <source/><italic toggle="yes">Proc Natl Acad Sci U S A</italic>. <year>2016</year>;<volume>113</volume>(<issue>9</issue>):<fpage>E1306</fpage>–<lpage>E1315</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1518189113</pub-id><pub-id pub-id-type="pmid">26884164</pub-id></mixed-citation>
</ref>
<ref id="CIT0067">
<label>67.</label>
<mixed-citation publication-type="journal"><string-name><surname>Belcheva</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Irrazabal</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Robertson</surname>
<given-names>SJ</given-names></string-name>, et al. <article-title>Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells</article-title>. <source/><italic toggle="yes">Cell</italic>. <year>2014</year>;<volume>158</volume>(<issue>2</issue>):<fpage>288</fpage>–<lpage>299</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2014.04.051</pub-id><pub-id pub-id-type="pmid">25036629</pub-id></mixed-citation>
</ref>
<ref id="CIT0068">
<label>68.</label>
<mixed-citation publication-type="journal"><string-name><surname>Pala</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Sieri</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Berrino</surname>
<given-names>F</given-names></string-name>, et al. <article-title>Yogurt consumption and risk of colorectal cancer in the Italian European prospective investigation into cancer and nutrition cohort</article-title>. <source/><italic toggle="yes">Int J Cancer</italic>. <year>2011</year>;<volume>129</volume>(<issue>11</issue>):<fpage>2712</fpage>–<lpage>2719</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ijc.26193</pub-id><pub-id pub-id-type="pmid">21607947</pub-id></mixed-citation>
</ref>
<ref id="CIT0069">
<label>69.</label>
<mixed-citation publication-type="journal"><string-name><surname>Toi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Hirota</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Tomotaki</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Probiotic beverage with soy isoflavone consumption for breast cancer prevention: a case-control study</article-title>. <source/><italic toggle="yes">Curr Nutr Food Sci</italic>. <year>2013</year>;<volume>9</volume>(<issue>3</issue>):<fpage>194</fpage>–<lpage>200</lpage>. doi:<pub-id pub-id-type="doi">10.2174/15734013113099990001</pub-id><pub-id pub-id-type="pmid">23966890</pub-id></mixed-citation>
</ref>
<ref id="CIT0070">
<label>70.</label>
<mixed-citation publication-type="journal"><string-name><surname>Naito</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Koga</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Yamaguchi</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Prevention of recurrence with epirubicin and lactobacillus casei after transurethral resection of bladder cancer</article-title>. <source/><italic toggle="yes">J Urol</italic>. <year>2008</year>;<volume>179</volume>(<issue>2</issue>):<fpage>485</fpage>–<lpage>490</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.juro.2007.09.031</pub-id><pub-id pub-id-type="pmid">18076918</pub-id></mixed-citation>
</ref>
<ref id="CIT0071">
<label>71.</label>
<mixed-citation publication-type="journal"><string-name><surname>Hibberd</surname>
<given-names>AA</given-names></string-name>, <string-name><surname>Lyra</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ouwehand</surname>
<given-names>AC</given-names></string-name>, et al. <article-title>Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention</article-title>. <source/><italic toggle="yes">BMJ Open Gastroenterol</italic>. <year>2017</year>;<volume>4</volume>(<issue>1</issue>):<fpage>e000145</fpage>. doi:<pub-id pub-id-type="doi">10.1136/bmjgast-2017-000145</pub-id></mixed-citation>
</ref>
<ref id="CIT0072">
<label>72.</label>
<mixed-citation publication-type="journal"><string-name><surname>Zheng</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>A randomised trial of probiotics to reduce severity of physiological and microbial disorders induced by partial gastrectomy for patients with gastric cancer</article-title>. <source/><italic toggle="yes">J Cancer</italic>. <year>2019</year>;<volume>10</volume>(<issue>3</issue>):<fpage>568</fpage>–<lpage>576</lpage>. doi:<pub-id pub-id-type="doi">10.7150/jca.29072</pub-id><pub-id pub-id-type="pmid">30719153</pub-id></mixed-citation>
</ref>
<ref id="CIT0073">
<label>73.</label>
<mixed-citation publication-type="journal"><string-name><surname>Jiang</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Xia</surname>
<given-names>C</given-names></string-name>, et al. <article-title>A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma</article-title>. <source/><italic toggle="yes">Cancer</italic>. <year>2019</year>;<volume>125</volume>(<issue>7</issue>):<fpage>1081</fpage>–<lpage>1090</lpage>. doi:<pub-id pub-id-type="doi">10.1002/cncr.31907</pub-id><pub-id pub-id-type="pmid">30521105</pub-id></mixed-citation>
</ref>
<ref id="CIT0074">
<label>74.</label>
<mixed-citation publication-type="journal"><string-name><surname>Redman</surname>
<given-names>MG</given-names></string-name>, <string-name><surname>Ward</surname>
<given-names>EJ</given-names></string-name>, <string-name><surname>Phillips</surname>
<given-names>RS</given-names></string-name>. <article-title>The efficacy and safety of probiotics in people with cancer: a systematic review</article-title>. <source/><italic toggle="yes">Ann Oncol</italic>. <year>2014</year>;<volume>25</volume>(<issue>10</issue>):<fpage>1919</fpage>–<lpage>1929</lpage>. doi:<pub-id pub-id-type="doi">10.1093/annonc/mdu106</pub-id><pub-id pub-id-type="pmid">24618152</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>